Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 10.65
-0.35 (-3.18%)
Dec 2, 2025, 4:13 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 750.88 million as of December 2, 2025. Its market cap has increased by 128.63% in one year.
Market Cap
750.88M
Enterprise Value
663.31M
Revenue
377.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.65
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has increased from 720.55M to 750.88M, an increase of 4.21%. That is a compound annual growth rate of 0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 750.88M | 87.07% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.59B |
| Nordhealth AS | 2.88B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.58B |
| ArcticZymes Technologies ASA | 1.15B |
| Omda AS | 955.66M |
| Vistin Pharma ASA | 886.89M |
| Gentian Diagnostics ASA | 829.72M |